Stockscreener 앱 받기
33.64
0.65%
-0.22
시간 외 거래:
33.66
0.02
+0.06%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TG Therapeutics stock sinks on profit miss - MSN
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook By Stocktwits - Investing.com India
TG Therapeutics: Q1 Earnings Snapshot - MySA
TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga
Why TG Therapeutics Stock Was Tumbling Today - AOL.com
TGTX Stock Dips Despite Surging Revenue and Profitability - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target - Investing.com
TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX) - Seeking Alpha
TG Therapeutics (TGTX) Stock Falls After Earnings Miss Despite Raised Guidance - GuruFocus
TG Therapeutics stock sinks on profit miss (TGTX:NASDAQ) - Seeking Alpha
Strong Q1 Performance for TG Therapeutics (TGTX) with BRIUMVI Growth - GuruFocus
Earnings call transcript: TG Therapeutics misses Q1 2025 EPS forecast, shares dip - Investing.com
TG Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic - MSN
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - Yahoo Finance
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire
TG Therapeutics (TGTX) Misses Q1 EPS Estimates, Raises 2025 Revenue Projections - GuruFocus
TG Therapeutics Inc (TGTX) Reports Q1 2025 Revenue of $119.7 Million, Surpassing Estimates - GuruFocus
TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated - marketscreener.com
TG Therapeutics Reports First Quarter 2025 Financial Results - TradingView
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance | TGTX Stock News - GuruFocus
TG Therapeutics Q1 revenue beats estimates, stock edges higher By Investing.com - Investing.com Canada
TG Therapeutics Q1 revenue beats estimates, stock edges higher - Investing.com
TGTX Surpasses Revenue Expectations with Strong Q1 Performance | TGTX Stock News - GuruFocus
Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.03, vs. FactSet Est of $0.17 - marketscreener.com
Earnings Flash (TGTX) TG Therapeutics Reports Q1 Revenue $120.9M, vs. FactSet Est of $117.9M - marketscreener.com
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire Inc.
TG Therapeutics Earnings Loom With Stock (NASDAQ: TGTX) Outperforming Market - AskTraders.com
When (TGTX) Moves Investors should Listen - news.stocktradersdaily.com
TG Therapeutics (TGTX) Schedules Q1 2025 Earnings Call - GuruFocus
TG Therapeutics (TGTX) Poised for Major Earnings Growth in Q1 - GuruFocus
TG Therapeutics stock soars to 52-week high of $45.28 By Investing.com - Investing.com India
TG Therapeutics stock soars to 52-week high of $45.28 - Investing.com
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
TG Therapeutics to Host Conference Call on First Quarter 2025 Fi - GuruFocus
TG Therapeutics to Host Conference Call on May 5, 2025, to Discuss Q1 Financial Results and 2025 Outlook - Nasdaq
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update - GlobeNewswire
Investor Network: TG Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm - ACCESS Newswire
TG Therapeutics (NasdaqCM:TGTX) Sees Profitable Turn With Strong Quarterly Earnings - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
TG Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
TG Therapeutics Reaches Analyst Target Price - Nasdaq
0.84%
0.15%
자본화:
|
볼륨(24시간):